Supplementary Methods from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression through Misregulation of LCN2Guangcun Cheng, Jianhua Wang(Xinjiang Medical University)UnknownMarch 30, 202310.1158/0008-5472.22401660Cited by 0SaveCiteExport RISWatch citationsRelated PapersHistone-lysine N-methyltransferase SETD7 is a potential serum biomarker for colorectal cancer patients|EBioMedicine|2018|40Supplementary Figure Legend from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression through Misregulation of LCN2|Unknown|2023|0